Special Educational Needs: support in England
An overview of the current system of support for children and young people with special educational needs, and pressure on the system. Updated with new 2024-25 SEND incidence and EHC plan data

On 12 November 2020, at 1.30pm, there will be a debate in Westminster Hall on “The effect of the covid-19 outbreak on breast cancer diagnosis and the future of breast cancer services”. The debate will be led by Craig Tracey MP. The Library has produced a short debate pack with background material, statistics, parliamentary proceedings and news material relevant to the debate.
The effect of the covid-19 outbreak on breast cancer diagnosis and the future of breast cancer services (220 KB , PDF)
The effect of the covid-19 outbreak on breast cancer diagnosis and the future of breast cancer services (220 KB , PDF)
An overview of the current system of support for children and young people with special educational needs, and pressure on the system. Updated with new 2024-25 SEND incidence and EHC plan data
The Rare Cancers Bill 2024-2025 had its second reading on Friday 14 March 2025. It was considered in Public Bill Committee on 2 July 2025 and report stage is scheduled for 11 July 2025. This is a private members' bill.
This briefing focuses on two disease-modifying dementia drugs that are currently being appraised by the National Institute for Health and Care Excellence (NICE): lecanemab and donanemab